Evidence map›Paper›PMID 38213670›Full record

ArticleInternational journal of MS care

The Role of Clinical Pharmacists in Patient-Centric Comprehensive Multiple Sclerosis Care.

Jacquelyn Bainbridge, Rebecca Barnhart, Ryan Fuller, Van T Hellerslia, Julie Kidd, Steven Merrill, Emily Volger, Jenelle H Montgomery

Open access · diamondAbstract read
In one paragraph

Article in International journal of MS care. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 8 institutions in 1 country.

Jacquelyn BainbridgeFrom the Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA (JB).ORCID https://orcid.org/0000-0001-5649-1564
Rebecca BarnhartUniversity of Colorado Health, Ambulatory Care Pharmacy Services, Aurora, CO, USA (RB).
Ryan FullerHospital of the University of Pennsylvania, Philadelphia, PA, USA (RF).
Van T HellersliaTemple University School of Pharmacy; Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA (VTH).
Julie KiddRoanoke Area MS Center, Salem, VA, USA (JK).
Steven MerrillUCSF MS & Neuroinflammation Center, UCSF Medical Center, San Francisco, CA, USA (SM).
Emily VolgerNovartis Pharmaceuticals Corporation, East Hanover, NJ, USA (EV).
Jenelle H MontgomeryDuke University Hospital, Durham, NC, USA (JHM).
Duke University Hospital · USHospital of the University of Pennsylvania · USNovartis (United States) · USSalem VA Medical Center · USTemple University · USUniversity of California San Francisco Medical Center · USUniversity of Colorado Anschutz Medical Campus · USUniversity of Colorado Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIndividuals with multiple sclerosis (MS) may experience a variety of visible and invisible symptoms and, as they age, comorbidities related and unrelated to their MS. This can result in a complex medication regimen that includes disease-modifying therapies, symptom management drugs, and prescriptions for other comorbid disorders.

methodsWe reviewed the existing literature to discover how to optimally integrate neurology clinical pharmacists into the MS care team and how clinical pharmacists can directly support both providers and patients through their expertise in pharmacology and medication management.

resultsWith approaches founded on a shared decision-making process alongside neurology providers, patients, and care partners, clinical pharmacists can help meet the complex challenges of MS care in a variety of ways. Especially within MS clinics, they are well positioned to enhance current neurology practices given their extensive training in comprehensive medication management and their ability to identify nuances in medication management to promote pharmacovigilance and patient-centered care.

conclusionsNeurology clinical pharmacists bring multifaceted medication management and patient counseling and education skills to the MS care team and can support the shared decision-making process by serving as an accessible resource for patients and clinicians. By building trusted partnerships between neurology providers and clinical pharmacists, MS care teams can achieve effective and efficient patient care. Future research should compare clinical and patient-reported outcomes between patients receiving standard care and those receiving multidisciplinary, pharmacist-integrated care.

Indexed as

disease-modifying therapymultiple sclerosisneurology clinical pharmacistpatient-centered carePharmD

Identifiers

PMID38213670
PMCPMC10779712
OpenAlexW4385764783

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.